Hormone Replacement Therapy Market To Worth USD 36.54 Billion by 2027 | CAGR 8.20% NeighborWebSJ – NeighborWebSJ

Hormone Replacement Therapy Market is valued at USD 21.04 Billion in 2020 and expected to reach USD 36.54 Billion by 2027 with the CAGR of 8.20% over the forecast period.

Global Hormone Replacement Therapy Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027The growing awareness on post-menopausal issues among women is one of the major factors driving the growth of Global Hormone Replacement Therapy Market.

Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/1402

Scope of Global Hormone Replacement Therapy Market Report-

Hormone replacement therapy is a treatment used to release symptoms of the menopause. The main advantage is that it is a very effective method of controlling menopausal symptoms, and it can make an important difference to a womans quality of life and security. Hormone replacement therapy can also reduce a womans risk of developing osteoporosis and cancer of the colon and rectum. Additionally, hormones are secreted predominantly from the endocrine glands and absorbed into the bloodstream. The hormones that have been most commonly utilised in hormone replacement therapy are progesterone, estrogen, testosterone, adrenal hormones, DHEA, thyroid hormones, pregnenolone, melatonin, and human growth hormone. It is the most effective treatment for menopause symptoms. Systemic hormone replacement therapy helps in treating cancer, rheumatoid arthritis and other diseases. Moreover, this treatment is particularly favorable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. It may also protect against osteoporosis.

Global Hormone Replacement Therapy market report is segmented on the basis of product, administration, disease and region & country level. Based upon product, global hormone replacement therapy market is classified into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy and testosterone replacement therapy. Based upon administration, the market is divided into oral, parenteral and transdermal. Based upon disease, global hormone replacement therapy market is classified into menopause, hypothyroidism, male hypothyroidism, growth hormone deficiency, cancer and other.

The regions covered in this Hormone Replacement Therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Hormone Replacement Therapy sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Afria, etc.

Key Players for Hormone Replacement Therapy

Global Hormone Replacement Therapy report covers prominent players Abbott Laboratories, Novo Nordisk, Novartis, Merck Serono, Bayer Healthcare, Eli Lilly, Mylan Laboratories, Roche, Genentech, Orion Pharma AB, Allergen Plc and others.

News-

Big Study Found No Rise in Death Risk among Women who Took Hormone Therapy

September 12th, 2017; after a massive study of hormone replacement therapy was halted due to higher rates of breast cancer, heart attack and stroke among women assigned to the drugs to treat menopausal symptoms, a new follow-up study has found those women had no higher risk of death as of 2014 than participants who took a placebo.

The Growing Awareness about Hormone Replacement is the Key Factor Influencing the Global Hormone Replacement Therapy Market Growth.

Increasing healthcare expenditure due to growing awareness about health related problems. For example, According to OECD, the US spent $10,209 on healthcare per capita, or per person, in 2017. Thats more than any other country in OECDs 36-country consortium, and over $2,000 more than Switzerland, the second-highest spending country. In addition, rising drug development and hormonal imbalance disorders with rising geriatric population are also boosting the hormone replacement therapy market growth. Additionally, the rising womens population between the age group of 45 to 60, which increases the range of menopausal window due to this factor the demand of hormonal replacement therapy, is also growing. However, the hormone replacement therapy has number of side effects which may hamper the market growth. For example, fluid retention, indigestion, headache, and depression, bloating, swelling, nausea, leg cramps. Combined hormone replacement therapy slightly increases the risk of developing breast cancer, womb cancer, ovarian cancer and stroke. For example, Women who take hormone replacement therapy for more than 1 year have a higher risk of breast cancer than women who never use hormone replacement therapy. The risk is linked to all types of hormone replacement therapy except vaginal oestrogen. In spite of that, technological advancements in this field may create the number of opportunities within the forecast period.

North America is expected to Dominate the Global Hormone Replacement Therapy Market

North America is expected to dominate the global hormone replacement therapy market due to the increasing awareness about the hormonal replacement therapy And Increasing number of womens which have menopause problems in this region. For example, National Center for Biotechnology Information, in the United States, approximately 1.3 million women become menopausal each year and, 1% of women experience premature menopause before the age of 40. The Asia Pacific is expected to experience surge of demand too, owing to the factors such as increased awareness levels among the end users and improving healthcare infrastructure. Rising geriatric population is one of the primary factors responsible for the growth of the hormonal replacement therapy marketin the Europe.

Hormone Replacement TherapyMarketReport Coverage

Key Benefits for Global Hormone Replacement Therapy Market Report-

Global Hormone Replacement Therapy Market Segmentation:

By Product:

By Administration:

By Disease:

By Regional & Country Analysis:

Continued

Get Full Report: https://brandessenceresearch.com/healthcare/hormone-replacement-therapy-market-size

https://www.marketwatch.com/press-release/blood-collection-market-for-covid-19-impact-with-business-stats-growth-perspective-size-trends-and-forecast-2021-2027-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/australia-breakfast-cereal-market-2021-size-share-industry-growth-business-statistics-top-leaders-competitive-landscape-forecast-to-2027-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/india-ceramic-3d-printing-market-research-report-size-2021-share-region-wise-analysis-of-top-players-growth-rate-application-and-forecast-by-2027-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/us-concrete-surface-retarders-market-trends-growth-outlook-by-top-company-development-and-growth-factors-by-regions-overview-to-2027-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/at-475-cagr-construction-equipment-rental-market-size-set-to-register-usd-16223-billion-by-2025-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/construction-plastics-market-by-plastic-types-end-user-trends-size-share-global-industry-report-2027-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/asia-container-security-market-2021-2027-historical-analysis-growth-size-positively-impact-demand-and-supply-sales-revenue-values-price-trends-opportunity-key-manufacture-industry-share-and-forecast-2021-02-02?tesla=y

https://www.marketwatch.com/press-release/crowdfunding-market-business-overview-upcoming-trends-and-top-company-analysis-forecast-by-2025-2021-02-01?tesla=y

https://www.marketwatch.com/press-release/uk-cryogenic-valve-market-company-profiles-segments-size-landscape-demand-and-recent-trends-industry-analysis-business-outlook-current-and-future-growth-by-2027-2021-02-02?tesla=y

https://neighborwebsj.com/

Read the original post:
Hormone Replacement Therapy Market To Worth USD 36.54 Billion by 2027 | CAGR 8.20% NeighborWebSJ - NeighborWebSJ